In ADM’s latest investment moves, the company will be acquiring Georgia-based Deerland Probiotics & Enzymes. This is in line with its strategic campaign to expand current product offerings of health and wellness products. Customers of today are, more than ever, prioritizing health and well-being, showing a growing demand for nutritious food, beverages and supplements. The acquisition is set to be completed in the coming weeks.
Deerland focuses on probiotic and dietary supplements. The business currently has 12 branded product lines that target digestive health, immune health, women’s health, and cardiovascular health, to name a few. It also includes spore probiotics in its offerings, which feature enhanced stability for wider use in food and beverages.
“Deerland Probiotics & Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the U.S. and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers. We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our Health & Wellness business and support growth across our Nutrition business unit.” ADM Chairman and CEO Juan Luciano
“The hand-in-glove fit of Deerland’s vast portfolio of branded technologies, clinical studies and world-class dosage form production capabilities combined with ADM’s Health and Wellness solutions is strong and unparalleled, allowing us to provide our dietary supplement, food/beverage and companion animal customers with a much broader array of products and capabilities,” said Scott Ravech, Deerland Probiotics & Enzymes CEO. “The Deerland team could not be more excited at the opportunity to be a part of the ADM family.”